Elin's Sparkle Fund

Raising funds for research into acute lymphoblastic leukaemia (ALL)

Funds Raised
Fundraising Pages
Elin's family has discovered first-hand how important research is after her relapse, and want to raise money to support further research into acute lymphoblastic leukaemia and in particular high risk, relapsed and refractory ALL while Elin continues treatment. Here, they tell her story...

Elin was diagnosed with ALL in 2016 at just 2 years old. She underwent a gruelling 2 and a half years of chemotherapy at Alder Hey Children’s Hospital in Liverpool which she completed in November 2018, just after she had started school. Sadly, in January 2019 our family discovered that she had relapsed. Since then, Elin, now 5 years old has been undergoing treatment once again.

Unfortunately, relapsed leukaemia is much more difficult to treat and therefore part of her treatment is a new therapy called CAR-T therapy which is being trialled at Manchester Children’s Hospital.

This is very new treatment to the UK and our hope is that this will provide a better outcome than the traditional treatment path. It has involved more chemotherapy and a process where Elin’s own cells have been extracted and engineered to fight the leukaemia when they are reinfused. It has been another tough path for Elin and our family as she has been isolated at home and in hospital since she relapsed although she remains strong and never complains.

Make a donation to Elin's Sparkle Fund
Open an online fundraising page for Elin's Sparkle Fund
Set up a regular Direct Debit donation to Elin's Sparkle Fund

Follow on Twitter

Supporter pages

Text CCLG 5 ELIN to 70300 to donate £5. 

CCLG will receive 100% of your donation. You may also be charged for one text message at your network’s standard or charity rate.

You can make a donation or pay in funds raised by cheque, payable to CCLG, to CCLG, Century House, 24 De Montfort Street, Leicester LE1 7GB. Please ensure you make it clear that the donation is for Elin's Sparkle Fund so that your donation is allocated to the correct fund. 

100% of funds raised support research into acute lymphoblastic leukaemia (ALL) and in particular high risk, relapsed and refractory ALL.